Literature DB >> 9353099

Altered lymphocyte antigen expressions in HIV infection: a study by quantitative flow cytometry.

L Ginaldi1, M De Martinis, A D'Ostilio, A Di Gennaro, L Marini, D Quaglino.   

Abstract

To identify surface antigen changes that may contribute to the immune deficiency in infection with the human immunodeficiency virus (HIV), we quantified, by double-staining flow cytometry, the number of antigens of the main peripheral blood lymphocyte subsets from 30 HIV-positive persons and compared them with those of 19 HIV-negative healthy donors. Standard microbeads with different capacities to bind mouse immunoglobulins were used to convert the mean fluorescence intensity values into numbers of antigen molecules per cell, measured as antibody binding capacity. The level of expression of different lymphocyte antigens in HIV-infected patients differs from that seen in normal blood lymphocytes. Some of these surface markers are decreased, whereas others are increased, and their expression is modulated depending on the specific cell subset considered. The expression of CD3, CD4, and CD8 on T lymphocytes is significantly decreased; moreover, CD3 is down-regulated on activated and nonactivated T lymphocytes and on CD4 and CD8 cells. In contrast, the expression of CD2 on T cells is significantly increased. Natural killer cells exhibit down-regulation of CD7, normal levels of CD8 and CD56, and overexpression of CD2. Our results also identified, for most of these antigens, quantitative differences in membrane expression according to different disease stages, as assessed by the CD4 T-cell count. Quantitative flow cytometry therefore may provide useful insights into the lymphocyte functional defects characterizing HIV infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353099     DOI: 10.1093/ajcp/108.5.585

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  Analysis of Epstein-Barr virus (EBV) receptor CD21 on peripheral B lymphocytes of long-term EBV- adults.

Authors:  W J Jabs; M Paulsen; H J Wagner; H Kirchner; H Klüter
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Regeneration and tolerance factor: a correlate of human immunodeficiency virus-associated T-cell activation.

Authors:  T S Givens; B K DuChateau; J S Boomer; M P Westerman; A Gilman-Sachs; K D Beaman
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

3.  Quantitation of Lan antigen in Lan+, Lan+(w) and Lan- phenotypes.

Authors:  Rhiannon S McBean; Brett Wilson; Yew-Wah Liew; Catherine A Hyland; Robert L Flower
Journal:  Blood Transfus       Date:  2015-02-26       Impact factor: 3.443

4.  Human immunodeficiency virus type 2 produces a defect in CD3-gamma gene transcripts similar to that observed for human immunodeficiency virus type 1.

Authors:  I Segura; C Delmelle-Wibaut; M Janssens; Y Cleuter; A van den Broeke; R Kettmann; K E Willard-Gallo
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

5.  Increased expression of regeneration and tolerance factor in individuals with human immunodeficiency virus infection.

Authors:  B K DuChateau; G W Lee; M P Westerman; K D Beaman
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

6.  Elevated KIR expression and diminished intensity of CD7 on NK cell subsets among treatment naïve HIV infected Ethiopians.

Authors:  Henok Andualem; Mulualem Lemma; Amare Keflie; Meseret Workeneh; Birhanu Ayelign; Yayehyirad Tassachew; Lidya Hailu; Alene Geteneh; Adane Mihret; Martha Zewdie; Rawleigh Howe
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

7.  Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages.

Authors:  Jing Qin Wu; Bin Wang; Larissa Belov; Jeremy Chrisp; Jenny Learmont; Wayne B Dyer; John Zaunders; Anthony L Cunningham; Dominic E Dwyer; Nitin K Saksena
Journal:  Retrovirology       Date:  2007-11-26       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.